It's the wave of the future in ESRD, regardless of 21% Medicare cuts:http://www.bizjournals.com/portland/stories/2010/06/14/daily21.html
I thought nxtm had the only HD machine and Baxter will follow in three to five years.
I thought the same thing, but emerging competition is great news and the article is a very good find. NXTM is way, way out in front. More awareness of this medical trend and market segment growth can only shine the spotlight on Next Stage.
philly, read the article. It is a start-up with a long way to go. Your thought is correct about the only machine.